This year’s multidisciplinary program reflects the AACR’s focus on the various facets of cancer etiology, progression, and treatment and the factors that influence each individual patient’s experience, including genetics, environment, and lifestyle factors.

This year’s class of 33 new Fellows joins the 256 distinguished scientists, clinicians, and physician-scientists previously honored with the AACR’s highest level of recognition.

Hunter is being honored for the discovery of protein tyrosine phosphorylation as a common cellular mechanism capable of contributing to cellular growth and proliferation and, in some cases, the development of cancer.

DuBois is being honored for elucidating the role of cyclooxygenase 2 in colon cancer and the contributions of the lipid metabolite prostaglandin E2 to tissue inflammation in the etiology of colon cancer.